Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Kyoji Okita, Toshihiko Matsumoto, Daisuke Funada, Maki Murakami, Koichi Kato, Yoko Shigemoto, Noriko Sato & Hiroshi Matsuda. (2022) Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography. Frontiers in Pharmacology 13.
Crossref
Crossref
Baoyu Shen, Dongxian Zhang, Xiaofeng Zeng, Lina Guan, Genmeng Yang, Liu Liu, Jian Huang, Yuanyuan Li, Shijun Hong & Lihua Li. (2022) Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway. Psychopharmacology 239:5, pages 1521-1537.
Crossref
Crossref
Kyoji Okita, Koichi Kato, Yoko Shigemoto, Noriko Sato, Toshihiko Matsumoto & Hiroshi Matsuda. (2021) Effects of an Adenosine A2A Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission Tomography. Frontiers in Neuroscience 15.
Crossref
Crossref
Julian Cheron & Alban de Kerchove d’Exaerde. (2021) Drug addiction: from bench to bedside. Translational Psychiatry 11:1.
Crossref
Crossref
Rowan Saloner, Mariana Cherner, Erin E. Sundermann, Caitlin Wei-Ming Watson, Jennifer E. Iudicello, Scott L. Letendre, Adarsh Kumar & Ronald J. Ellis. (2020) COMT val158met genotype alters the effects of methamphetamine dependence on dopamine and dopamine-related executive function: preliminary findings. Psychiatry Research 292, pages 113269.
Crossref
Crossref
Lauren K. Dobbs & Hitoshi Morikawa. (2020) Biasing Neurotensin Receptor Signaling to Arrest Psychostimulant Abuse. Cell 181:6, pages 1205-1206.
Crossref
Crossref
Courtney M Keller, Allyson L Spence, Misty W Stevens, S. Michael Owens, Glenn F Guerin & Nicholas E Goeders. (2019) Effects of a methamphetamine vaccine, IXT-v100, on methamphetamine-related behaviors. Psychopharmacology 237:3, pages 655-667.
Crossref
Crossref
M. Patel, C.D. Verrico & R. De La GarzaIIII. (2019) Rivastigmine does not alter cocaine-induced subjective effects or self-administration. Pharmacology Biochemistry and Behavior 185, pages 172758.
Crossref
Crossref
Marcello Solinas, Pauline Belujon, Pierre Olivier Fernagut, Mohamed Jaber & Nathalie Thiriet. (2018) Dopamine and addiction: what have we learned from 40 years of research. Journal of Neural Transmission 126:4, pages 481-516.
Crossref
Crossref
Marguerite M. Patel, David A. Nielsen, Thomas R. Kosten, Richard De La GarzaIIII, Thomas F. Newton & Christopher D. Verrico. (2018) FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. The American Journal on Addictions 27:7, pages 567-573.
Crossref
Crossref
Barak W. Gunter, Robert W. Gould, Michael Bubser, Kevin M. McGowan, Craig W. Lindsley & Carrie K. Jones. (2018)
Selective inhibition of M
5
muscarinic acetylcholine receptors attenuates cocaine self-administration in rats
. Addiction Biology 23:5, pages 1106-1116.
Crossref
Crossref
Silvia Antinori, Liana Fattore, Pierluigi Saba, Walter Fratta, Gian Luigi Gessa & Paola Devoto. (2018) Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex. Addiction Biology 23:2, pages 556-568.
Crossref
Crossref
Robert W Gould, Paul W Czoty, Linda J Porrino & Michael A Nader. (2016) Social Status in Monkeys: Effects of Social Confrontation on Brain Function and Cocaine Self-Administration. Neuropsychopharmacology 42:5, pages 1093-1102.
Crossref
Crossref
Mehmet Sofuoglu, James Poling, Theresa Babuscio, Kishorchandra Gonsai, Kevin Severino, Charla Nich & Kathleen M. Carroll. (2017) Carvedilol does not reduce cocaine use in methadone-maintained cocaine users. Journal of Substance Abuse Treatment 73, pages 63-69.
Crossref
Crossref
Anna Wzgarda, Robert Kleszcz, Monika Prokop, Katarzyna Regulska, Milosz Regulski, Jaroslaw Paluszczak & Beata J. Stanisz. (2017) Unknown face of known drugs – what else can we expect from angiotensin converting enzyme inhibitors?. European Journal of Pharmacology 797, pages 9-19.
Crossref
Crossref
Daryl Shorter, David A. Nielsen, Sara C. Hamon, Ellen M. Nielsen, Thomas R. Kosten, Thomas F. Newton & Richard De La Garza. (2016) The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenetics and Genomics 26:9, pages 428-435.
Crossref
Crossref
Christopher D. Verrico, Colin N. Haile, Richard De La GarzaIIII, Kenneth Grasing, Thomas R. Kosten & Thomas F. Newton. (2016) Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. International Journal of Neuropsychopharmacology 19:7, pages pyw029.
Crossref
Crossref
Natashia Swalve, John R. Smethells, Natalie E. Zlebnik & Marilyn E. Carroll. (2016) Sex differences in reinstatement of cocaine-seeking with combination treatments of progesterone and atomoxetine. Pharmacology Biochemistry and Behavior 145, pages 17-23.
Crossref
Crossref
Steven T. Pittenger, Scott T. Barrett, Shinnyi Chou & Rick A. Bevins. (2016) The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats. Behavioural Brain Research 300, pages 150-159.
Crossref
Crossref
E.D. London. 2016. Neuropsychopharmacology: A Tribute to Joseph T. Coyle. Neuropsychopharmacology: A Tribute to Joseph T. Coyle
67
84
.
Sarah A. Kromrey, Robert W. Gould, Michael A. Nader & Paul W. Czoty. (2015) Effects of prior cocaine self-administration on cognitive performance in female cynomolgus monkeys. Psychopharmacology 232:11, pages 2007-2016.
Crossref
Crossref
Helen Fox, Mehmet Sofuoglu & Rajita Sinha. (2015) Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals. Journal of Psychopharmacology 29:3, pages 312-323.
Crossref
Crossref
L. Jing, Y. Zhang & J.-X. Li. (2014) Effects of the Trace Amine Associated Receptor 1 Agonist RO5263397 on Abuse-Related Behavioral Indices of Methamphetamine in Rats. International Journal of Neuropsychopharmacology 18:4, pages pyu060-pyu060.
Crossref
Crossref
Christopher D. Verrico, Colin N. Haile, James J. Mahoney III, Daisy G.Y. Thompson-Lake, Thomas F. Newton & Richard De La Garza II. (2014) Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study. Drug and Alcohol Dependence 141, pages 72-78.
Crossref
Crossref
R. De La GarzaIIII, G.P. Galloway, T.F. Newton, J. Mendelson, C.N. Haile, E. Dib, R.Y. Hawkins, C.-Y.A. Chen, J.J. MahoneyIIIIII, J. Mojsiak, G. Lao, A. Anderson & R. Kahn. (2014) Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 50, pages 44-52.
Crossref
Crossref
Thomas F. Kresina, Robert Lubran & H. Westley Clark. (2014) Issues in the Care and Treatment of HCV/HIV Co-Infection for Key Populations in Resource-Constrained Settings. Health 06:14, pages 1803-1815.
Crossref
Crossref
Helen Fox & Rajita Sinha. 2014. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse
217
265
.
Shen-Chieh Chang & Winston W. Shen. (2013) Stimulants, Wakefulness-promoting Agents, and Nonstimulant Attention Deficit Hyperactivity Disorder Medications. Journal of Experimental & Clinical Medicine 5:6, pages 210-216.
Crossref
Crossref